Hensel, Manfred <br/><br/>
Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma.  [electronic resource] 

 -  Clinical lymphoma & myeloma  Sep 2005 
 - 131-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1557-9190 
<br/><br/><label>Standard No.: </label>10.3816/CLM.2005.n.039  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immunoglobulin M--blood<br/>Leukemia, Lymphocytic, Chronic, B-Cell--blood<br/>Male<br/>Middle Aged<br/>Pentostatin--administration & dosage<br/>Remission Induction<br/>Rituximab<br/>Waldenstrom Macroglobulinemia--blood